1 / 12

Clinical and simulation outcomes of a multifocal intraocular lens with rotational asymmetry and two different levels of

Clinical and simulation outcomes of a multifocal intraocular lens with rotational asymmetry and two different levels of near addition. Jorge Alió, MD,PhD 1,2 Luis J Moreno, MSc 1,2 Ana B Plaza, MSc 1 David P Piñero, PhD 1 1 VISSUM Corporation. Alicante.

crwys
Download Presentation

Clinical and simulation outcomes of a multifocal intraocular lens with rotational asymmetry and two different levels of

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical and simulation outcomes of a multifocal intraocular lens with rotational asymmetry and two different levels of near addition Jorge Alió, MD,PhD1,2 Luis J Moreno, MSc1,2 Ana B Plaza, MSc1 David P Piñero, PhD1 1VISSUM Corporation. Alicante. 2Department of Pathology and Surgery. University Miguel Hernández, Alicante.

  2. Financial Disclosure for Jorge Alió, MD,PhD Abbott Medical Optics D AcuFocus D Akkolens A, D Alcon Laboratories D Bausch & Lomb A, D Carl Zeiss Meditec D Chemedica D Eyemaginations A Index Instruments P IntraLase Corporation D LenSx A,D Mediphacos A Novagali Pharma D Nulens D, P Oculentis A, D OSN/SLACK A Presbia A SCHWIND eye-tech-solutions D, E Springer P Tekia P Thea D

  3. Clinical and simulation outcomes of a multifocal intraocular lens with rotational asymmetry and two different levels of near addition PURPOSE: To evaluate and compare the visual acuity outcomes of a multifocal intraocular lens with rotational asymmetry and two different levels of addition and correlate these outcomes with computer simulations at different distances. Clinical results are compared with mathematical simulations. SETTING: Vissum Corporation, Alicante, Spain METHODS: 43 consecutive eyes of 26 cataract patients (age range 55-83 years) were divided into two groups: group A, 22 eyes implanted with the Lentis Mplus LS-312 MF15 IOL (Oculentis); group B, 21 eyes implanted with the Lentis Mplus LS-312 MF30 IOL (Oculentis). Distance, near and intermediate visual acuity outcomes were evaluated preoperatively and postoperatively during a 6-month follow up. Additionally, postoperative contrast sensitivity, patient satisfaction, ocular aberrations, ocular optical quality and defocus curve were analyzed.

  4. LENTIS Mplus LS-312 MF Mplus IOL is built virtually. Curvature data and asphericity are estimated. The mathematical analysis has been performed in Vissum Alicante, Spain. Distance zone Near zone

  5. Mathematical simulations We used Navarro eye model and thought a ray tracing we chose the power of the Mplus IOL that minimized the size of far focus Sclera Light for far focus Iris Light Retina Light for near focus Pupil

  6. We used Mplus with 15.5 diopters because it provided the best focus out of all the different powers available in today’s market.

  7. We compared two versions of Mplus: LS-312 MF15 with 1.5 diopters of addition and LS-312 MF30 with 3.0 diopters of addition. Optical quality was computed as the size of the focus (in microns, μm) in the retina. The smaller the focus, the better the optical quality was. For distance vision (6m / 20′), both versions gave the same optical quality. For intermediate vision (80cm / 2′8′′) the version with 1.5 diopters gave more optical quality, whereas for near vision (40cm / 1′4′′), the version with 3.0 diopters gave more optical quality.

  8. Clinical results Preoperative Conditions: Both groups were comparable. No significant differences were found among them.

  9. Clinical results 6 months follow up: There is no significant differences in Uncorrected Distance Visual Acuity (LogMAR UDVA). However, the group A (+1.5) showed a better uncorrected intermediate visual acuity (LogMAR UIVA) than group B (+3.0) and group B showed a better uncorrected near visual acuity (LogMAR UNVA) than group A

  10. Defocus curve Lentis Mplus LS-312 MF15Better visual acuity for defocus levels of +1.50, +2.0 and +2.5 D (Mann-Whitney test, p0.04).Lentis Mplus LS-312 MF30Better visual acuity for defocus level of -0.50 D (Mann-Whitney test, p=0.03). Good vision with +1.5, +2.0 and +2.5 D of defocus is in relation with intermediate and distance vision. This better intermediate visual function was consistent with the better values of UIVA obtained. On the other hand, the +3.0 D of addition IOL was found to provide a better visual outcome for a level of defocus of –0.5 D, which was in relation with the ability of seeing sharply at distances less than 33 cm (near vision).

  11. Conclusions Lentis Mplus LS-312 MF30 and MF15 IOLs are able to restore successfully the distance visual function after cataract surgery and to provide an improvement in intermediate vision, with also a complete near visual rehabilitation with the MF30 model. Lentis Mplus LS-312 MF30 and MF15 IOLs provides a excellent distance vision. LS-312 MF30 provides a better visual acuity for near distance than LS-312 MF15, however LS-312 MF15 provides a better visual acuity for intermediate vision than LS-312 MF30. Clinical results are consistent with mathematical simulations.

  12. Thank you! Luis J Moreno MsC Jorge Alió, MD,PhD Ana Belén Plaza MSc David Piñero PhD

More Related